Literature DB >> 15523301

Evidence-based decision limits for cardiac troponin: low-level elevation and prognosis.

David A Morrow.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15523301     DOI： 10.1016/j.ahj.2004.05.024

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

1.  The effect of cardiac troponin testing on clinical care in a veterans population: a randomized controlled trial.

Authors:  Michael Berkwits; A Russell Localio; Stephen E Kimmel
Journal:  J Gen Intern Med       Date:  2005-07       Impact factor: 5.128

2.  N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study.

Authors:  Madeline R Sterling; Raegan W Durant; Joanna Bryan; Emily B Levitan; Todd M Brown; Yulia Khodneva; Stephen P Glasser; Joshua S Richman; George Howard; Mary Cushman; Monika M Safford
Journal:  BMC Cardiovasc Disord       Date:  2018-04-16       Impact factor: 2.298

3.  Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study.

Authors:  Monika M Safford; Gaurav Parmar; Codrin S Barasch; Jewell H Halanych; Stephen P Glasser; David C Goff; Ronald J Prineas; Todd M Brown
Journal:  BMC Health Serv Res       Date:  2013-05-01       Impact factor: 2.655
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.